| Literature DB >> 27528712 |
Helen E Speedy1, Ben Kinnersley1, Daniel Chubb1, Peter Broderick1, Philip J Law1, Kevin Litchfield1, Sandrine Jayne2, Martin J S Dyer2, Claire Dearden3, George A Follows4, Daniel Catovsky5, Richard S Houlston1,5.
Abstract
Chronic lymphocytic leukemia (CLL) can be familial; however, thus far no rare germ line disruptive alleles for CLL have been identified. We performed whole-exome sequencing of 66 CLL families, identifying 4 families where loss-of-function mutations in protection of telomeres 1 (POT1) co-segregated with CLL. The p.Tyr36Cys mutation is predicted to disrupt the interaction between POT1 and the telomeric overhang. The c.1164-1G>A splice-site, p.Gln358SerfsTer13 frameshift, and p.Gln376Arg missense mutations are likely to impact the interaction between POT1 and adrenocortical dysplasia homolog (ACD), which is a part of the telomere-capping shelterin complex. We also identified mutations in ACD (c.752-2A>C) and another shelterin component, telomeric repeat binding factor 2, interacting protein (p.Ala104Pro and p.Arg133Gln), in 3 CLL families. In a complementary analysis of 1083 cases and 5854 controls, the POT1 p.Gln376Arg variant, which has a global minor allele frequency of 0.0005, conferred a 3.61-fold increased risk of CLL (P = .009). This study further highlights telomere dysregulation as a key process in CLL development.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27528712 PMCID: PMC5271173 DOI: 10.1182/blood-2016-01-695692
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113